European Experience with a New Thoracic Device. D.Böckler University Hospital Heidelberg Germany
|
|
|
- Allan Shields
- 5 years ago
- Views:
Transcription
1 European Experience with a New Thoracic Device D.Böckler University Hospital Heidelberg Germany
2 Disclosures Speaker name: Dittmar Böckler I have the following potential conflicts of interest to report: Consulting Employment in industry Stockholder of a healthcare company Owner of a healthcare company Research Grant I do not have any potential conflict of interest
3 Influencing Factors of Outcome after TEVAR Patient related Factors Device related Factors Procedure & operator related factors Ref: Böckler et al., CX 2015 Book Chapter, Biba Medical
4 TEVAR - Limitations in the Past Material fatigue Bird-beaking Collapse
5 Device Modifications and its on Impact of Conformability
6 Conformable GORE TAG Thoracic Endoprosthesis Conformable TAG Designed to treat multiple etiologies o o o Aneurysm Traumatic Transection Type B Dissection Engineered to be conformable and compression resistant in 6-33% oversizing conditions 20 years of clinical history More than 125,000 devices distributed 10 clinical studies and a global registry data
7 4-5 Years Results with CTAG (mean 2 yrs.) Prospective Multicentre Regulatory US- Study 1 Prospective Multicentre Europen Registry 2 GREAT Registry unpublished Single Center Experience 2 Heidelberg Experience (407 devices/163 pat.) unpublished HUMAN STUDY eissn Med Sci Monit Basic Res, 2015; 21: DOI: /MSMBR Received: Accepted: Published: Device Conformabilit y and Morphological Assessment Af t er TEVAR for Aortic Type B Dissect ion: A Single-Cent re Experience with a Conformable Thoracic Stent-Graf t Design Authors Contribution: Study Design A Data Collection B Statistical Analysis C Data Interpretation D Manuscript Preparation E Literature Search F Funds Collection G ABCDEF 1 BCD 2 BEF 1 EF 1 ACDE 1 Corresponding Author: Source of support: Background: Material/Methods: Results: 1Jordan Moritz S. Bischoff Matthias Müller-Eschner Katrin Meisenbacher Andreas S. Peters Dittmar Böckler 1 Department of Vascular and Endovascular Surgery, Heidelberg University Hospital, Heidelberg, Germany 2 Department of Radiodiagnostics and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany Dittmar Böckler, dittmar.boeckler@med.uni-heidelberg.de Departmental sources The aim of this study was to analyze device conformability in TEVARof acute and chronic (a/c) type B aortic dissections (TBAD) using the Gore Conformab le Thoracic Aortic Stent-graft (CTAG). From January 1997 to February 2014, a total of 90 out of 405 patients in our center received TEVARfor TBAD. Since November 2009, 23 patients (16 men; median age: 62 years) were treated with the CTAG. Indications were complicated atbad in 15 (65%) and expanding ctbad in 8 (35%) patients. Primary endpoints were the assessment of device conformability by measuring the distance (D) from the radiopaque gold band marker (GM) at the proximal CTAG end to the inner curvature (IC) of the arch on parasagittal multiplanar reformations of CT angiography, as well as the evaluation of aortic diameter changes following TEVAR. Median follow-up was 13.3 months (range: 2 days to 35 months). Primary and secondary success rates were 91.3%(21/23) and 95.6%(22/23), respectively. There was 1 type Ia endoleak, retrograde dissection or primary conversion was not observed. Median GM-IC-D was 0 mm (range: 0 mm to 10 mm). GM-IC-Dwas associated with zone 2 placement compared to zone 3 (P=0.036). There was no association between GM-IC-D formation and arch type. In atbad cases the true lumen significantly increased after TEVAR(P=0.017) and the false lumen underwent shrinkage (P=0.025). In ctbad patients the false lumen decreased after TEVAR(P=0.036). The CTAGshows favorable conformability and wall apposition in challenging arch pathologies such as TBAD., JVS 2015, 2Böckler EJVES 2016, 3 Bischoff Med Sci Research 2015, 3Böckler,Endovascular Today 2014 Conclusions:
8 CTAG Aneurysm Study (USA) 1 Jordan W et al., JVS 2015:61: sites: 66 patients all aneurysms (DTAA) Oct Sept d results: Mortality 1.5 % Any SAE 23 % Paraplegia 2 % Stroke 2 % 2 yrs. results Type Ia Endoleak 3.2 % TAA rupture 0 % 5 mm decrease 86%
9 European Prospective CTAG Registry 5 sites: 100 patients 56 TAA, 32 B-Diss., 4 Trauma 30 day Results Technical success 92 % Mortality 3.3% Complication rate 34 % Stroke rate 11% 2 yr. Results Overall survival 74% - Elective 80% - Emergency 62% Böckler, Brunkwall, Taylor, Mangilardi, Larzon EJVES. 2016;51:
10 GREAT - Real World Registry
11 GREAT - Real World Registry
12 TEVAR Experience Heidelberg (n=532) March 1997 November TEVAR -Procedures 190 Pat. (male 58%; mean age 66 yrs.) 295 CTAG Devices Mean 1.5 devices per patient 80% arch involvement (Zone 0-3)
13 Heidelberg Single Center 6 yr Experience 30 day Results: Technical success 97,5 % Mortality 3.3% Follow up Results: Reintervention rate 21 % Overall mortality (43/166) 26 % Aortic related mortality 8/166) 5 %
14 CTAG-Conformability in B-Dissection HUMAN STUDY eissn Med Sci Monit Basic Res, 2015; 21: DOI: /MSMBR ABCDEF 1 BCD 2 BEF 1 EF 1 ACDE 1 Device Conformability and Morphological Assessment After TEVAR for Aortic Type B Dissection: A Single-Centre Experience with a Conformable Thoracic Stent-Graft Design Moritz S. Bischoff Matthias Müller-Eschner Katrin Meisenbacher Andreas S. Peters Dittmar Böckler 1 Department of Vascular and Endovascular Surgery, Heidelberg University Hospital, Heidelberg, Germany 2 Department of Radiodiagnostics and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany N = 1 (5,0%) N = 13 (65,0%) N = 6 (30,0%) Author:, dittmar.boeckler@med.uni-heidelberg.de Apposition to inner wall 100% No association between apposition and arch type Less apposition in LZ 2 versus 3 (p=0.03) (21/23) and 95.6% (22/23), respectively. There was 1 type Ia endoleak, retrograde dissection or primary conversion was not observed. Median GM-IC-D was 0 mm (range: 0 mm to 10 mm). GM-IC-D was associated with zone 2 placement compared to zone 3 (P=0.036). There was no association between GM-IC-D formation and arch type. In atbad cases the true lumen significantly increased 3 BischofffM, Blckler D, Med Sci Research 2015,
15 19 Years of Stent Graft Evolution TAG 1998 Conformable TAG 2009 CTAG with active control 2017
16 CTAG with ACTIVE CONTROL System Staged deployment enables adjustment of placement and angulation Continuous blood flow ensures hemodynamic stability Opportunities to visualize & refine device placement C-arm parallax correction Device placement
17 CTAG with ACTIVE CONTROL System Intuitive deployment system allow phsyicians to focus on the patient, not the deployment system Optional steps can be skipped Lockwire keeps stent graft attached to catheter throughout the procedure, enhancing control of the stent graft
18 CTAG with ACTIVE CONTROL System
19 Partial deployment and active control
20 Early Heidelberg Experience since July 17 (n = 13 patients, 20 devices) N=6 - PostCoA -Aneurysm - B-Dissection - PAU N=2 - DTA aneurysm - B-Dissection N=1 - Arch Aneurysm (out of recent IFU) N=4 - TEVAR-Redo w. distal extension - TAA - chronic B-Diss. - PAU
21 CTAG- Personal Experience in 190 pat. & 295 implants (20 with active control) approved for aneurysms, dissections, traumatic transection radial force adapted to underlying disease highly conformable > ideal for aortic arch pathologies short precurved nose cone > zone 0 (ascending!) unsheathed > multiple devices with one access partial deployment > paralaxis correction, no rapid pacing fixed on stent graft system, total placement control deployment distal to proximal > accurate at celiac trunk time to optimize accuracy, angulation and apposition
22 GORE TAG Thoracic Branch Endoprosthesis Intended for treatment of the aortic arch and descending thoracic aorta Aortic Component Side Branch (SB) Component Aortic Extender (Optional) Optional TBE accessory GORE DrySeal Side Branch Delivery Sheath (SBDS) European Experience to be awaited CAUTION: Investigational Device. Limited by United States law to investigational use only.
23 GORE TAG Thoracic Branch Endoprosthesis US Clinical Experience Zone 2 Feasibility completed enrollment - 31 patients Zone 2 Zone 1 Zone 0 Zone 0/1 Early Feasibility completed enrollment - 9 patients US pivotal IDE trial began enrolling in Sept Min 175 patients, Max. 435 CAUTION: Investigational Device. Limited by United States law to investigational use only.
24 Conclusions TEVAR in the arch remains very challenging Various factors influence TEVAR Device design & performance> high impact on results New devices are about to overcome limitations CTAG with active control is but needs larger experience and longer follow up Thoracic branch endoprosthesis awaited in Europe
25 European Experience with a New thoracic device D.Böckler University Hospital Heidelberg Germany
Going the distance: Conformable Gore TAG device demonstrates durable outcomes over the long. D.Böckler University Hospital Heidelberg, Germany
Going the distance: Conformable Gore TAG device demonstrates durable outcomes over the long D.Böckler University Hospital Heidelberg, Germany Disclosures Speaker name: Dittmar Böckler I have the following
Is a Paradigm Shift towards Early Endovascular Treatment of Type B Dissection justified?
Is a Paradigm Shift towards Early Endovascular Treatment of Type B Dissection justified? Dittmar Böckler Department of Vascular and Endovascular Surgery University of Heidelberg, Germany Disclosure Speaker
Introducing the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System
Introducing the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System K. Oikonomou Department of Vascular Surgery Regensburg University Disclosures W.L. Gore & Associates Sponsored Presentation
Indications for use. Contraindications within the United States
Indications for use Indications within the United States The GORE TAG Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta, including: Isolated lesions
THE THE MORE MORE NATURAL APPROACH TO OPTIMAL FIT
THE THE MORE MORE NATURAL APPROACH Natural Approach TO Optimal Fit TO OPTIMAL FIT Conformability without Compromise THE STANDARD IN Conformability AND Designed for flexibility and conformability in tortuous
Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment
Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment Robert Y. Rhee, MD Chief, Vascular and Endovascular Surgery Director, Aortic Center Maimonides Medical Center Brooklyn,
Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry
University of Milan Thoracic Aortic Research Center Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry Santi Trimarchi, MD, PhD Associate
How to achieve a successful proximal sealing in TEVAR? Pr L Canaud
How to achieve a successful proximal sealing in TEVAR? Pr L Canaud CHU de Montpellier France Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic. Proximal neck
Santi Trimarchi, MD, PhD Vascular Surgeon Thoracic Aortic Research Center, Director IRCCS Policlinico San Donato University of Milan
The Gore GREAT Registry: Update about a real life data collection Santi Trimarchi, MD, PhD Vascular Surgeon Thoracic Aortic Research Center, Director IRCCS Policlinico San Donato University of Milan Disclosures
GORE TAG Thoracic Endoprosthesis ANNUAL CLINICAL UPDATE SEPTEMBER 2018 Abstract. Section I GORE TAG Device Clinical experience. Section II Conformable
GORE TAG Thoracic Endoprosthesis ANNUAL CLINICAL UPDATE SEPTEMBER 08 Abstract This annual clinical update provides a review of the ongoing experience with the GORE TAG Thoracic Endoprosthesis There have
Management of intramural hematoma and penetrating ulcers - what is different? D.Böckler University Hospital Heidelberg, Germany
Management of intramural hematoma and penetrating ulcers - what is different? D.Böckler University Hospital Heidelberg, Germany Disclosure Speaker name: Dittmar Böckler I have the following potential conflicts
Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany
Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany Disclosures Speaker name: Dittmar Böckler I have the following potential conflicts
Current State of Thoracic Branch Devices and Ongoing Clinical Trials
Current State of Thoracic Branch Devices and Ongoing Clinical Trials Hiroo Takayama, MD, PhD Associate Professor of Surgery Director of Cardiovascular Institute Co-Director of Aortic Center NY Presbyterian/Columbia
Jean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS. Arch Pathology: The Endovascular Era is here
Jean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS Arch Pathology: The Endovascular Era is here Disclosures Consultant: Cook Medical, Bolton Medical, Medtronic Inc, Volcano,
DISCLOSURES ISOLATED DTA LESION? TYPE B DISSECTIONS TREATMENT OPTIONS
Endovascular Repair of Aortic Arch Pathologies; What is available/possible in the U.S. in 2018? Kaiser Permanente Endovascular Symposium 6/2/18 Sukgu M Han, MD, MS Assistant Professor of Clinical Surgery
Objective assessment of current stent grafts: which graft for which lesion. Ludovic Canaud, MD, PhD Pierre Alric, MD, PhD Montpellier, France
Objective assessment of current stent grafts: which graft for which lesion Ludovic Canaud, MD, PhD Pierre Alric, MD, PhD Montpellier, France Conflict of interest: none 1 Introduction Different diseases
The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations
The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations Joseph V. Lombardi, MD Professor & Chief, Division of Vascular & Endovascular Surgery Department of Surgery,
Development of Stent Graft. Kato et al. Development of an expandable intra-aortic prothesis for experimental aortic dissection.
Development of Stent Graft Kato et al. Development of an expandable intra-aortic prothesis for experimental aortic dissection. ASAIO J 1993 The New England Journal of Medicine Downloaded from nejm.org
Title. Different arch branched devices are available, is morphology the. main criteria of choice? Ciro Ferrer, MD
Different arch branched devices are available, is morphology the Title main criteria of choice? Ciro Ferrer, MD Vascular Surgery Unit Sapienza University of Rome Disclosure Speaker name: Ciro Ferrer Proctoring/speaking
Thoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure
Thoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure Tilo Kölbel, MD, PhD University Heart Center Hamburg University Hospital Eppendorf Disclosure Speaker name: Tilo Kölbel, MD I
Treatment of complex thoracic cases Focus on the new Gore Active Control TAG device
Treatment of complex thoracic cases Focus on the new Gore Active Control TAG device Professor Christoph A. Nienaber The Royal Brompton and Harefield NHS Trust Cardiology and Aortic Centre C.Nienaber@rbht.nhs.uk
Mid-term results from ANCHOR: How does this data influence the treatment algorithm for hostile EVAR anatomies
Mid-term results from ANCHOR: How does this data influence the treatment algorithm for hostile EVAR anatomies Jean-Paul P.M. de Vries Head Department of Surgery, University Medical Centre Groningen The
Optimal Treatment of Chronic Dissection
Optimal Treatment of Chronic Dissection Chun-Che Shih 施俊哲 MD, Ph.D. Chief, Professor Institute of Clinical Medicine National Yang Ming University Division of Cardiovascular Surgery Taipei Veterans General
Predictors of abdominal aortic aneurysm sac enlargement after EVAR Longterm results from the ENGAGE Registry
Predictors of abdominal aortic aneurysm sac enlargement after EVAR Longterm results from the ENGAGE Registry D. Böckler Department of Vascular and Endovascular Surgery University Hospital Heidelberg Disclosure
Endovascular Management of Thoracic Aortic Pathology Stéphan Haulon, J Sobocinski, B Maurel, T Martin-Gonzalez, R Spear, A Hertault, R Azzaoui
Endovascular Management of Thoracic Aortic Pathology Stéphan Haulon, J Sobocinski, B Maurel, T Martin-Gonzalez, R Spear, A Hertault, R Azzaoui Aortic Center, Lille University Hospital, France Disclosures
ADSORB trial results: Is it enough to switch the paradigm?
ADSORB trial results: Is it enough to switch the paradigm? Jan Brunkwall, MD, PhD Professor and Chairman Complications to acute type B dissection Mortality Rupture Organ Ischemia Dilatation/Aneurysm Refractory
Clinical Trials of Acute and Chronic Dissections. Gregory Landry MD
Clinical Trials of Acute and Chronic Dissections Gregory Landry MD No disclosures Acute vs chronic dissection: Definitions 1950s: Acute < 2 weeks, Chronic > 2 weeks 2013: European Interdisciplinary Consensus
Arch Repair with the Bolton Medical RelayBranch Thoracic Stent-graft system: Multicenter experience
Arch Repair with the Bolton Medical RelayBranch Thoracic Stent-graft system: Multicenter experience Joost van Herwaarden, MD, PhD University Medical Center, Utrecht Disclosure I have the following potential
Pioneering EVAR techniques in aortic dissection
Pioneering EVAR techniques in aortic dissection Jianing Yue, Weiguo Fu Department of Vascular Surgery Zhongshan Hospital Fudan University Shanghai, China LINC Asia-Pacific 2016 March 8-10, 2016 Hong Kong
Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak
Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic, Gore Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s)
RETROGRADE BRANCH. Gustavo S. Oderich MD Professor of Surgery Director of Endovascular Therapy Division of Vascular and Endovascular Surgery
RETROGRADE BRANCH Gustavo S. Oderich MD Professor of Surgery Director of Endovascular Therapy Division of Vascular and Endovascular Surgery FACULTY DISCLOSURE Consulting* Cook Medical Inc., WL Gore Research
Development of a Branched LSA Endograft & Ascending Aorta Endograft
Development of a Branched LSA Endograft & Ascending Aorta Endograft Frank R. Arko III, MD Sanger Heart & Vascular Institute Carolinas Medical Center Charlotte, North Carolina, USA Disclosures Proximal
Understanding the Predictors of Aneurysmal Degeneration in Type B Dissection
Understanding the Predictors of Aneurysmal Degeneration in Type B Dissection A case example illustrating when early endovascular intervention may provide the best outcome. BY DITTMAR BÖCKLER, MD, PhD;
Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft
Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft Frank R. Arko III, MD Professor of Cardiovascular Surgery Director, Endovascular Surgery Co-Director, Aortic Institute Carolinas Medical
Access More Patients. Customize Each Seal.
Access More. Customize Each Seal. The Least Invasive Path Towards Proven Patency ULTRA LOW PROFILE TO EASE ADVANCEMENT The flexible, ultra-low 12F ID Ovation ix delivery system enables you to navigate
ADVANCING ENDOVASCULAR OPTIONS
Supplement to March 2018 ADVANCING ENDOVASCULAR OPTIONS NEW ENDOVASCULAR DEVICES AND INSIGHTS TO EXTEND AORTIC TREATMENT TO MORE PATIENTS. CONTENTS 4 Early Experience Using the GORE TAG Conformable Thoracic
Role of Gender in TEVAR and EVAR results from the GREAT registry
Role of Gender in TEVAR and EVAR results from the GREAT registry Mauro Gargiulo Vascular Surgery University of Bologna - DIMES Policlinico S.Orsola-Malpighi Bologna, Italy mauro.gargiulo2@unibo.it Disclosure
Re-interventions after TEVAR:
Re-interventions after TEVAR: How often does it occur and what are procedures most commonly utilized to treat these issues? Pacific Northwest Endovascular Conference Seattle, WA June 15, 2018 PENN Surgery
Treatment options of late failures of EVAS. Michel Reijnen Rijnstate Arnhem The Netherlands
Treatment options of late failures of EVAS Michel Reijnen Rijnstate Arnhem The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts of interest to report: Consulting
Technique and Outcome of Laser Fenestration For Arch Vessels
Technique and Outcome of Laser Fenestration For Arch Vessels Jean M. Panneton MD, FRCSC, FACS Professor of Surgery Chief & Program Director Division of Vascular Surgery Eastern Virginia Medical School
Global Evidence for the Treatment of Type B Aortic Dissection
Global Evidence for the Treatment of Type B Aortic Dissection Ross Milner, MD Professor of Surgery Director, Center for Aortic Diseases September 17, 2016 Disclosures Consultant Cook, Endospan, Medtronic,
The Role of Stent-Grafts in Marfan Syndrome
The Role of Stent-Grafts in Marfan Syndrome James H. Black, III, MD, FACS The David Goldfarb, MD, Associate Professor of Surgery Chief, Division of Vascular Surgery and Endovascular Therapy The Johns Hopkins
EVAR Revision Setting - How can Heli-FX EndoAnchors improve the outcomes?
D. Böckler Department of Vascular and Endovascular Surgery University Hospital Heidelberg EVAR Revision Setting - How can Heli-FX EndoAnchors improve the outcomes? Disclosures Speaker name: Dittmar Böckler
Low profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster
Low profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster Disclosure Speaker name:...michel Bosiers... I have the following potential conflicts of interest to report: Consulting Employment
Neurological Complications of TEVAR. Frank J Criado, MD. Union Memorial-MedStar Health Baltimore, MD USA
ISES Online Neurological Complications of Frank J Criado, MD TEVAR Union Memorial-MedStar Health Baltimore, MD USA frank.criado@medstar.net Paraplegia Incidence is 0-4% after surgical Rx of TAAs confined
Conformable Gore TAG Thoracic Endoprosthesis for the treatment of thoracic aortic aneurysms
device evaluation Conformable Gore TAG Thoracic Endoprosthesis for the treatment of thoracic aortic aneurysms Traditional open repair of descending thoracic aortic aneurysms is effective, although potentially
Standardization of the CHEVAR procedure: How a standard approach has improved outcomes. Prof Peter Holt St George s, London
Standardization of the CHEVAR procedure: How a standard approach has improved outcomes Prof Peter Holt St George s, London Disclosure Speaker name: Prof Peter Holt I have the following potential conflicts
Influence of patient selection and IFU compliance on outcomes following EVAS
Influence of patient selection and IFU compliance on outcomes following EVAS LUNCH SYMPOSIUM LINC 2017 Jan MM Heyligers, MD, PhD, FEBVS Consultant Vascular Surgeon Elisabeth TweeSteden Hospital Tilburg,
Management of Acute Aortic Syndromes. M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria
Management of Acute Aortic Syndromes M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria I have nothing to disclose. Acute Aortic Syndromes Acute Aortic Dissection Type
UC SF Early Intervention in Type B Dissection: Results From the INSTEAD XL Trial. Acute Type B Dissection. Outline. Disclosures.
Early Intervention in Type B Dissection: Results From the INSTEAD XL Trial None Disclosures Jade S. Hiramoto, MD, MAS April 4, 2014 Outline Background Current treatment Results from INSTEAD trial Results
Tips and Tricks to Deliver a Stengraft to the Ascending Aorta
Tips and Tricks to Deliver a Stengraft to the Ascending Aorta Tilo Kölbel, MD, PhD University Heart Center University Hospital Eppendorf Hamburg, Germany Disclosures Research-grants, travelling, proctoring
Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice
Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice Eric Verhoeven, MD, PhD, A. Katsargyris, MD Department of Vascular and Endovascular Surgery, Paracelsus Medical University,
Percutaneous Approaches to Aortic Disease in 2018
Percutaneous Approaches to Aortic Disease in 2018 Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network Case 78 year old F Lower CP and upper
Endoanchor-assisted TEVAR
Endoanchor-assisted TEVAR May 29, 2015 NCVH2015 Grayson H. Wheatley III, MD Director of Aortic and Endovascular Surgery Associate Professor of Surgery Temple University School of Medicine Disclosures Consultant
Preliminary Data from the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis Early Feasibility Study
Preliminary Data from the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis Early Feasibility Study Mark A Farber, MD Professor of Surgery and Radiology Director, UNC Aortic Network University of North
OPEN REOPERATIONS FOR COMPLICATIONS OF ENDOVASCULAR AORTIC PROCEDURES: TIP OF THE ICEBERG?
OPEN REOPERATIONS FOR COMPLICATIONS OF ENDOVASCULAR AORTIC PROCEDURES: TIP OF THE ICEBERG? NICHOLAS T. KOUCHOUKOS, MD DIVISION OF CARDIOVASCULAR AND THORACIC SURGERY MISSOURI BAPTIST MEDICAL CENTER ST.
Thoracic aortic trauma A.T.O.ABDOOL-CARRIM ACADEMIC HEAD VASCULAR SURGERY DEPARTMENT OF SURGERY UNIVERSITY OF WITWATERSRAND
Thoracic aortic trauma A.T.O.ABDOOL-CARRIM ACADEMIC HEAD VASCULAR SURGERY DEPARTMENT OF SURGERY UNIVERSITY OF WITWATERSRAND Thoracic Aortic Trauma In USA and CANADA 7500-8000 die of blunt thoracic aortic
First in Human Experience with the Gore Conformable Excluder Endoprosthesis
A new conformable abdominal endovascular device First in Human Experience with the Gore Conformable Excluder Endoprosthesis Robert Y. Rhee, MD Chief, Vascular and Endovascular Surgery Director, Maimonides
How to Categorize the Infrarenal Neck Properly? I Van Herzeele Dept. Thoracic and Vascular Surgery, Ghent University, Belgium
How to Categorize the Infrarenal Neck Properly? I Van Herzeele Dept. Thoracic and Vascular Surgery, Ghent University, Belgium Disclosure Speaker name: Isabelle Van Herzeele I have the following potential
Ascending Aorta: How I Do It.
Ascending Aorta: Is The Endovascular Approach Realistic? How I Do It. Tilo Kölbel, MD, PhD University Heart Center Hamburg University Hospital Eppendorf Disclosure Speaker name: Tilo Kölbel I have the
Endovascular Branched Aortic Arch Repair
Houston Aortic Symposium 2018 Endovascular Branched Aortic Arch Repair Nimesh D. Desai MD PhD Associate Professor of Surgery, University of Pennsylvania Co-Director, Penn Thoracic Aortic Surgery Program
UC SF An Algorithm to Choose Which Uncomplicated (Asymptomatic) Acute Type B Dissection Patients Should Undergo TEVAR. Disclosures.
An Algorithm to Choose Which Uncomplicated (Asymptomatic) Acute Type B Dissection Patients Should Undergo TEVAR Disclosures Royalties and research grant support from Cook Medical, Inc. Jade S. Hiramoto,
Clinical experience with a new thoracic stent graft system (Ankura TM ). Procedural analysis, 30 days and 6-month results in a single center study
Clinical experience with a new thoracic stent graft system (Ankura TM ). Procedural analysis, 30 days and 6-month results in a single center study Theodoros Kratimenos, MD Consultant, Interventional Radiologist
Ascending Aorta: Is The Endovascular Approach Realistic?
University Heart Center Hamburg GERMAN AORTIC CENTER UHC Ascending Aorta: Is The Endovascular Approach Realistic? Tilo Kölbel, Christian Detter, Yskert v. Kodolitsch, Sebastian Debus University Heart Center
Combined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR
Combined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR William J. Quinones-Baldrich MD Professor of Surgery Director UCLA Aortic Center UCLA Medical Center Los Angeles,
GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability. Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands
GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts
Acute dissections of the descending thoracic aorta (Debakey
Endovascular Treatment of Acute Descending Thoracic Aortic Dissections Nimesh D. Desai, MD, PhD, and Joseph E. Bavaria, MD Acute dissections of the descending thoracic aorta (Debakey type III or Stanford
Changing Spectrum of Re-Interventions following TEVAR. 31 st Annual Florida Vascular Society. PENN Surgery
Changing Spectrum of Re-Interventions following TEVAR 31 st Annual Florida Vascular Society PENN Surgery No Disclosures Background: Challenges of analyzing TEVAR Outcomes in regard to re-interventions
Abdominal and thoracic aneurysm repair
Abdominal and thoracic aneurysm repair William A. Gray MD Director, Endovascular Intervention Cardiovascular Research Foundation Columbia University Medical Center Abdominal Aortic Aneurysm Endografts
CUSTOM-MADE SCALLOPED THORACIC ENDOGRAFTS IN DIFFERENT HOSTILE AORTIC ANATOMIES
CUSTOM-MADE SCALLOPED THORACIC ENDOGRAFTS IN DIFFERENT HOSTILE AORTIC ANATOMIES A SERIES OF THREE CASE REPORTS Joel Sousa Department of Department of Angiology and Vascular Surgery Hospital S. João, Porto,
No Neck Is Needed! Treat the Aneurysm Instead! Andrew Holden, MD Associate Professor of Radiology Auckland City Hospital
No Neck Is Needed! Treat the Aneurysm Instead! Andrew Holden, MD Associate Professor of Radiology Auckland City Hospital Disclosures Andrew Holden, MBChB, FRANZCR No financial investment to disclose Investigator
Aggressive Resection/Reconstruction of the Aortic Arch in Type A Dissection
Aggressive Resection/Reconstruction of the Aortic Arch in Type A Dissection M. Grabenwoger Dept. of Cardiovascular Surgery Hospital Hietzing Vienna, Austria Disclosure Statement Consultant of Jotec, Hechingen,
Life after EVAR 1? The value of open repair for some patients reappears. D. Böckler University Hospital Heidelberg, Germany
Life after EVAR 1? The value of open repair for some patients reappears D. Böckler University Hospital Heidelberg, Germany Disclosure Speaker name: Dittmar Böckler I have the following potential conflicts
UC SF. Disclosures. Thoracic Endovascular Aortic Repair 4/24/2009. Management of Acute Dissections: Is There Still a Role for Open Surgery?
UC SF Management of Acute Dissections: Is There Still a Role for Open Surgery? Darren B. Schneider, M.D. Assistant Professor of Surgery and Radiology Division of Vascular Surgery University of California
Ascending Aorta: Is The Endovascular Approach Realistic?
Ascending Aorta: Is The Endovascular Approach Realistic? Tilo Kölbel, MD, PhD University Heart Center Hamburg University Hospital Eppendorf Disclosures Research-grants, travelling, proctoring speaking-fees,
Endovascular aortic stent grafts have forever
Identifying the Appropriate Thoracic Device Size How to correctly size a thoracic device in diameter, landing zone, and length. BY MICHAEL E. BARFIELD, MD, AND THOMAS S. MALDONADO, MD Endovascular aortic
Aortic stents, types, selection, tricks in deployment.
Aortic stents, types, selection, tricks in deployment. Hamdy Soliman.M.D,FSCAI Consultant of Cardiology&Head of Endovascular Unit National Heart Institute Endovascular Treatment of Thoracic Aortic Aneurysms
Talent Abdominal Stent Graft
Talent Abdominal with THE Xcelerant Hydro Delivery System Expanding the Indications for EVAR Treat More Patients Short Necks The Talent Abdominal is the only FDA-approved device for proximal aortic neck
Balloon Expandable Covered Stents. Suddenly a Crowded Space
Novel Balloon Expandable Covered Stents for Aorto-iliac Occlusive Disease: New Trial Data makes for an Interesting Balloon Expandable Covered Stents Comparison in Aorto-iliac Occlusive Disease: Andrew
Endovascular Ascending Repair: Is This the Next Frontier?
Endovascular Ascending Repair: Is This the Next Frontier? The 11 th Houston Aortic Symposium Session II: Ascending Aorta/Aortic Dissection (Proximal) February 15, 2018 Michael D. Dake, M.D. Thelma and
Insights from the PROTAGORAS/PERICLES Registries: impact on ChEVAR results
Insights from the PROTAGORAS/PERICLES Registries: impact on ChEVAR results Konstantinos P. Donas, Giovanni Torsello Department of Vascular Surgery St. Franziskus Hospital Münster, Germany Disclosure Speaker
What is the best treatment for False Lumen growth after type B Dissection
What is the best treatment for False Lumen growth after type B Dissection Nikolaos Tsilimparis, Fiona Rohlffs, Yuk Law, Sebastian Debus, Tilo Kölbel N. Tsilimparis, MD, PhD, FEBVS Deputy Head of German
Aortic Arch pathology options: Open,Hybrid, fenestration, Chimney or branched stent-graft?
Aortic Arch pathology options: Open,Hybrid, fenestration, Chimney or branched stent-graft? Chang Shu, M.D., Ph.D Vascular Surgery Center National Center for Cardiovascular Diseases. Fuwai Hospital, CAMS
Endovascular treatment of aortic arch using Relay branched stent grafts
Endovascular treatment of aortic arch using Relay branched stent grafts B. Saint-Lèbes Vascular surgery unit Rangueil Universitary hospital Toulouse France Disclosure of Interest Speaker name: SAINT-LEBES
Bilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry
Bilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry Michel MPJ Reijnen, MD, PhD Department of Vascular Surgery, Rijnstate Hospital
GORE EXCLUDER AAA Endoprosthesis ANNUAL CLINICAL UPDATE OCTOBER Section I Clinical experience. Section II Worldwide commercial experience
GORE EXCLUDER AAA Endoprosthesis ANNUAL CLINICAL UPDATE OCTOBER 2018 Abstract This annual clinical update provides a review of the ongoing experience with the GORE EXCLUDER AAA Endoprosthesis used in the
How to select FEVAR versus EVAR + endoanchors in short-necked AAAs
How to select FEVAR versus EVAR + endoanchors in short-necked AAAs Jean-Paul P.M. de Vries, Richte C.L. Schuurmann St. Antonius Hospital Nieuwegein, The Netherlands 21st Critical Issues Congress Nuernberg,
My personal experience with INCRAFT in standard and challenging cases
My personal experience with INCRAFT in standard and challenging cases G Pratesi, MD Vascular Surgery University of Rome Tor Vergata giovanni.pratesi@uniroma2.it Disclosure Speaker name: Giovanni Pratesi,
Is it time to stent the ascending aorta? Martin Czerny
Is it time to stent the ascending aorta? Martin Czerny Content Basic insights into pathological process Dissection induced geometry changes Initial attempts Dedicated programme Future developments Summary
Durable outcomes. Proven performance.
Durable outcomes. Proven performance. GORE EXCLUDER AAA Endoprosthesis GORE EXCLUDER Iliac Branch Endoprosthesis GORE EXCLUDER AAA Endoprosthesis The most-studied* EVAR stent graft designed for durable
Subclavian Artery Plug Embolization (SAPE study): a real experience about endovascular subclavian occlusion prior to thoracic vascular repair
Subclavian Artery Plug Embolization (SAPE study): a real experience about endovascular subclavian occlusion prior to thoracic vascular repair Simone Salvati, Luca Bertoglio, Alessandra Fittipaldi, Andrea
Conflicts of Interest. When and Why Complex EVAR in Tx of juxta/suprarenal AAA? Summary. Infrarenal EVAR for short necks 2y postop
When and Why Complex EVAR in Tx of juxta/suprarenal AAA? Tim Resch MD Vascular Center Skane University Hospital Conflicts of Interest COOK Medical - Consulting, Speakers Bureau, IP, Research support Medtronic
Is there a way to predict the risk in uncomplicated Type B aortic dissections? FRANS MOLL University Medical Centre Utrecht - Netherlands
Is there a way to predict the risk in uncomplicated Type B aortic dissections? FRANS MOLL University Medical Centre Utrecht - Netherlands Disclosures: - Consultant Philips Health Care - Best Doctors Overview
Jean M. Panneton, MD, FRCSC, FACS. Professor of Surgery, Chief & Program Director Division of Vascular Surgery. Norfolk, VA
Jean M. Panneton, MD, FRCSC, FACS Professor of Surgery, Chief & Program Director Division of Vascular Surgery Eastern Virginia Medical School Norfolk, VA The Houston Aortic Symposium Houston TX, February
Advances in Treatment of Traumatic Aortic Transection
Advances in Treatment of Traumatic Aortic Transection Himanshu J. Patel MD University of Michigan Medical Center Author Disclosures Consulting fees from WL Gore Inc. There is no disease more conducive
EXPERIENCE AFTER 500 ENDOLUMINAL STENT GRAFTS. DEVICES SPECIFIC OUTCOME AND LESSONS LEARNED.
EXPERIENCE AFTER 500 ENDOLUMINAL STENT GRAFTS. DEVICES SPECIFIC OUTCOME AND LESSONS LEARNED. A/Prof. B. Patrice Mwipatayi MD, MMed (Surg), MClinEd (Melb), FCS, FRACS Department of Vascular Surgery, Royal
Techniques For Endovascular Aortic Arch Repair. Mario Lachat, MD University Hospital of Zurich Matteo Orrico, MD San Camillo-Forlanini Hospital, Rome
Techniques For Endovascular Aortic Arch Repair Mario Lachat, MD University Hospital of Zurich Matteo Orrico, MD San Camillo-Forlanini Hospital, Rome Disclosure Speaker name: Mario Lachat Endospan, Jotec,
Improving Endograft Durability with EndoAnchors
Improving Endograft Durability with EndoAnchors William D. Jordan, Jr., M.D. John E. Skandalakis Chair in Surgery Professor and Chief Division of Vascular Surgery and Endovascular Therapy Emory University
The Auckland Experience with the Nellix EVAS System. Andrew Holden, MBChB, FRANZCR
The Auckland Experience with the Nellix EVAS System Andrew Holden, MBChB, FRANZCR Disclosure Speaker name: Associate Professor Andrew Holden I have the following potential conflicts of interest to report:
The Fate of Unexpected Events Occurring in Standard EVAR
The Fate of Unexpected Events Occurring in Standard EVAR Andrea Stella Alma Mater Studiorum - University of Bologna Disclosure Speaker name: Prof. Andrea Stella I have the following potential conflicts